Catalyst Wire Dossier Catalyst Wire Dossier

BRYHALI

HALOBETASOL PROPIONATE · Bausch Health US, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BRYHALI, covering 2018-11-06 to 2018-11-06. Get the full timeline:

Most recent: FDA Approved: BRYHALI — Original Application (Bausch Health US, LLC)

See pricing